In This Article:
Ventas, Inc. VTR is scheduled to report first-quarter 2025 results on April 30, after market close. The quarterly results are likely to display year-over-year growth in revenues and normalized funds from operations (FFO) per share.
In the last reported quarter, this Chicago-based healthcare real estate investment trust (REIT) delivered a normalized FFO per share of 81 cents, beating the Zacks Consensus Estimate by a penny. The quarterly results reflected better-than-anticipated revenues. Ventas’ same-store cash net operating income for the total property portfolio increased year over year.
Ventas’ normalized FFO per share surpassed the Zacks Consensus Estimate in three of the trailing four quarters and met in the remaining period, with the average beat being 1.98%. The graph below depicts this surprise history:
Ventas, Inc. Price and EPS Surprise
Ventas, Inc. price-eps-surprise | Ventas, Inc. Quote
Factors at Play
In the first quarter, Ventas’ senior housing operating portfolio (SHOP) is likely to have benefited from an aging U.S. population and a rise in healthcare expenditure by this age cohort, which is generally higher than the average population. With the segment witnessing positive net move-ins, occupancy is expected to have remained high.
A well-diversified tenant base with long-term leases is expected to have contributed well to stable rental revenue generation, boosting the top line.
However, the outpatient medical and research portfolio segments are likely to be affected during the to-be-reported quarter.
Further, high interest expenses are expected to have cast a pall on the company’s performance to some extent.
VTR’s Q1 Projections
The Zacks Consensus Estimate for first-quarter resident fees and services is pegged at $909 million, suggesting an increase from $813.3 million reported in the year-ago period.
The Zacks Consensus Estimate for first-quarter triple-net leased properties' rental income is pegged at $157.2 million, suggesting an increase from the $155.4 million reported in the year-ago period.
The Zacks Consensus Estimate for first-quarter revenues is currently pegged at $1.30 billion, implying an 8.7% increase from the prior-year quarter’s reported figure.
Ventas’ activities during the soon-to-be-reported quarter were adequate to gain analysts’ confidence. The Zacks Consensus Estimate for first-quarter FFO per share has increased a cent upward to 82 cents over the past week. The figure implies an increase of 5.1% from the year-ago quarter’s reported number.
However, the consensus mark for outpatient medical and research portfolio rental income for the first quarter is pegged at $216.9 million, indicating a decline from $218.9 million reported in the year-ago period.